Artificial Intelligence
Impact of COVID-19 on User and Entity Behavior Analytics Market ; Segmented:: By Component, By Deployment Type, By End user, And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
New York, May 05, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Impact of COVID-19 on User and Entity Behavior Analytics Market ; Segmented:: By Component, By Deployment Type, By End user, And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031” – https://www.reportlinker.com/p06272881/?utm_source=GNW
Product Overview
Banking fraud, insider threat, & targeted attacks can all be detected using user and entity behavior analytics. This method is used to analyze human behavior patterns and then find deviations using statistical analysis and algorithms. When end users collaborate, malware might become dormant and go undiscovered. Rather than trying to figure out where the outsider got in, user and entity behavior analytics uses algorithms to detect internal threats, allowing for faster detection. In big data platforms like Apache Hadoop, user and entity behavior analytics solutions are utilized to analyze petabytes of data, detect insider risks, and detect sophisticated persistent threats. The collected data is evaluated to identify various human behavioral patterns used to identify odd behavior and threats.
Market Highlights
Global User and Entity Behavior Analytics market is expected to project a notable CAGR of 40.6% in 2031.
Increased cyber threats faced by insiders in businesses, as well as the inability of standard security systems to detect such insider threats, are driving the global market. Furthermore, the global market is expected to be driven by a lack of skilled security professionals who understand the privacy risk faced by users, as organizations have been expected to prefer behavior analytic solutions that rely on ML to identify such threats with minimal human interaction.
Global User and Entity Behavior Analytics: Segments
Solution component segment to grow with the highest CAGR during 2021-31
Based on Component, User and Entity Behavior Analytics Market has been segmented Solution and Services. Threats, compromised identities, data loss protection, and other solution segments are used to classify the market. Insider threats in the Solution segment are providing the highest share of the global user & entity behavior analytics market during the forecast period. Because firms know the crucial need of preventing insider breaches, insider threat measures are in a growing market. Organizations are significantly spending on hazard detecting analytical solutions to disclose security concerns that cybercriminals may abuse, which is driving the economy for UEBA solutions, which is driving the market for smart technology and security solutions.
Financial services and insurance segment to grow with the highest CAGR during 2021-31
By End-users the market is segmented into Government and Defense, Energy and Utilities, Healthcare, Retail and e-commerce, Financial Services, and Insurance, IT and Telecom, Others. The risk of cyber-crime increases as the number of customers in the insurance, accounting, and finance industries expands. As a result, these businesses generally use the UEBA because it provides customers with instant access to deposit & payment services. UEBA systems enable rapid threat detection and notify the organization of a wide range of behavioral patterns and potential insider threats, attracting end-users to the market.
Market Dynamics
Drivers
Increasing demand for real-time analytics.
The usage of User & Entity Behavior Analytics broadens the security perimeter to include closed networks, users, cloud service providers, as well as weird and smart endpoint devices. User behaviors are monitored and assessed using UEBA systems, which provide real-time & continuous monitoring. More on the COVID-19 epidemic Many industries have been pushed to operate online as a result of the impact, which has increased the risk of cyber security & thus the demand for UEBA.
Rising adoption of a user-centric approach
The requirement to prevent insider risk faced by users is one of the market’s beneficial elements. As a result of the growing volume of data breaches and enormous investment in threats prevention technologies, demand for user & entity behavior analytics is likely to rise rapidly throughout the projection period. With the increased demand for advanced security solutions, businesses are heavily investing in attacks detection analytical solutions to reveal security concerns that criminals may exploit, which is driving demand for user & entity behavior analytics solutions. Insider threats, information security, external attacks, & identity, and access management are all covered by this system.
Restraint
Scarcity of trained security personnel and a lack of public awareness
The dearth of qualified security personnel and lack of awareness of advanced insider threats are two challenges that hinder the growth of the user & entity behavior analytics industry. In addition, the global market’s growth is hampered by a user-centric approach and insufficient budget allocation for user and behavior analytics solutions.
Global User and Entity Behavior Analytics: Key Players
Amazon Web Services, Inc.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Bay Dynamics, Inc.
Dtex Systems Inc.
Exabeam, Inc.
Gurucul
Rapid7 Inc.
Securonix, Inc.
Splunk, Inc.
Varonis Systems, Inc.
Other Prominent Players
Global User and Entity Behavior Analytics: Regions
Global User and Entity Behavior Analytics market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Because of the rising use of consumer and organizational functional analytics solutions, the North American region is expected to hold the greatest share of the worldwide market throughout the forecast period. The increase in user behavior analytics security can be attributed to the rising usage of mobile & online apps in the sector, as well as the need for security solutions capable of spotting data risks. Due to increased investment in safety surveillance technology for the protection of citizens, the market is expected to rise during the forecasted period. In addition, the government is investing in Artificial Intelligence, 5G, cloud, IoT, and networking.
Impact of Covid-19 on User and Entity Behavior Analytics Market
The devastating impact of the widespread COVID-19 pandemic has stifled the User & Entity Behavior Analytics Market’s growth potential. As a result of the COVID-19 outbreak, many sectors have been forced to operate online, raising the risk of cyber security therefore, as a result, the need for UEBA has expanded. The International User and Entity Behavior Analytics (UEBA) Technology Market is expected to grow fast as a result of the growing digital presence, offering new opportunities over the anticipated period.
Global User and Entity Behavior Analytics is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
the Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Global User and Entity Behavior Analytics report also contains analysis on:
User and Entity Behavior Analytics Segments:
By Component
Solution (Insider Threats, Compromised Credentials, Data Loss Prevention, and Others)
Services (Implementation and Ongoing Optimization)
By Deployment Type
On-Premises
Cloud
By End-user
Financial Services & Insurance
Retail & Ecommerce
Energy & Utilities
IT & Telecom
Healthcare
Defense & Government
Others
User and Entity Behavior Analytics Dynamics
User and Entity Behavior Analytics Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
User and Entity Behavior Analytics Market Report Scope and Segmentation
Report Attribute Details
The market size value in 2021 USD 645.6 million
The revenue forecast in 2031 USD 19,481.6 million
Growth Rate CAGR of 40.6% from 2021 to 2031
The base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2031
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Component, Deployment Type, End-User, and Region
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled Amazon web services Inc., Bay Dynamics, Inc., Dtex Systems Inc., Exabeam, Inc., Gurucul, Rapid7 Inc., Securonix, Inc., Splunk, Inc., Varonis Systems, Inc., and Other Prominent Players
Read the full report: https://www.reportlinker.com/p06272881/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Artificial Intelligence
Signant Health extends eCOA leadership position through operational innovations that reduce timelines by at least one-third
PHILADELPHIA, May 8, 2024 /PRNewswire/ — Signant Health, the leader in evidence generation for modern clinical trials, announced today that it has substantially reduced implementation timelines for its flagship eCOA solution, TrialMax®. By leveraging process and technology enhancements, Signant’s operational teams can reduce the time it takes to go live with electronic patient-reported outcomes solutions by thirty percent or more.
Sponsors and Contract Research Organizations (CROs) have relied on Signant’s eCOA solution for over 20 years. The solution is known for its flexibility, reliability, scientific support, global logistics support, and ability to scale to any size trial, anywhere in the world. Traditionally, the time to bring the system live for patients and sites was commensurate with the operational complexity and trial design.
According to the company, customers can now benefit from this highly customizable eCOA solution along with Signant’s leading levels of science, scale, and service – delivered under much faster timelines.
“We are excited to offer customers the best of both worlds,” said Sanjiv Waghmare, Signant’s chief product officer. “They can get the fully featured, market-leading eCOA solution they already use and love, at a much faster pace. We believe this is especially meaningful as trial designs continue to increase in complexity. We want to ensure our customers hit their FPFV dates and start collecting high quality data without worrying about if their eCOA solution will be available.”
According to Waghmare, Signant’s engineering and operational teams identified areas where process enhancements and automation could dramatically reduce common implementation steps regardless of trial complexity. These steps cover all aspects of a typical eCOA timeline including study build, testing, translations, scale management, and validation.
“This is just the beginning of our efforts to deliver complexity at speed, with outstanding quality,” continued Waghmare. “We are also bringing additional efficiencies to our processes that will accelerate post-implementation support, including reporting, analytics, and data change management.”
Signant also offers a tenured solution for eCOA studies as part of its Signant SmartSignals® Unified Platform, which is fully integrated with EDC, RTSM, eConsent, and telemedicine. For more information about all Signant’s eClinical solutions, go to www.signanthealth.com.
About Signant Health
Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at www.signanthealth.com.
Contact:
Heather [email protected]+1 610.400.4141
Logo – https://mma.prnewswire.com/media/1202052/Signant_Health_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/signant-health-extends-ecoa-leadership-position-through-operational-innovations-that-reduce-timelines-by-at-least-one-third-302138773.html
Artificial Intelligence
Ness Digital Engineering Acquires Intricity – a New York based company specializing in data strategy, governance, modernization, and monetization
NEW YORK, May 8, 2024 /PRNewswire/ — Ness Digital Engineering (Ness), a global full-lifecycle digital services transformation company, has acquired Intricity, a leading provider of data strategy, governance, modernization, and monetization solutions. The acquisition deepens Ness’s data offerings, which global F1000 clients have utilized to create new revenue streams and improve operating efficiencies.
“Ness has always had a strong capability in data engineering, and the acquisition of Intricity brings the data strategy and advisory capability. Furthermore, Ness will build on Intricity’s strategic alliances with Snowflake and Databricks,” said Ranjit Tinaikar, CEO, Ness Digital Engineering. “We are excited to welcome Intricity’s talented team to Ness, combining our strengths to deliver even greater value to our clients.”
Intricity brings deep expertise in handling complex data modernization and monetization problems that are the heart of any digital transformation today.
“Joining Ness, backed by KKR, presents an exciting opportunity to accelerate our growth trajectory worldwide. We are excited to leverage Ness’s global presence, digital competencies, and deep industry expertise to deliver digital transformation solutions to a wider range of clients,” said Arkady Kleyner, Principal & Co-Founder, Intricity. “Together, we are well-positioned to drive meaningful business outcomes and accelerate innovation for our clients.”
Commenting on the acquisition, Troy Clemente, Principal & Co-Founder, Intricity, added, “We have successfully established ourselves as experts covering the entire information lifecycle, and by joining Ness, we can accelerate our combined clients’ AI journeys based on modern data infrastructures.”
Zinnov acted as financial advisor to Ness Digital Engineering.
For more information:Tanaya Misra, Global Head – PR & [email protected]
About Ness Digital Engineering
Ness Digital Engineering, which funds managed by global investment firm KKR acquired in 2022, is a full-lifecycle digital engineering firm offering digital advisory through scaled engineering services. Headquartered in New York, Ness serves our customers across 11 innovation hubs in the US, Eastern Europe, and India. Combining our core competence in engineering with the latest in digital strategy and technology, we seamlessly manage Digital Transformation journeys from strategy through execution to help businesses thrive in the digital economy. For more information, visit www.ness.com.
Logo: https://mma.prnewswire.com/media/2144213/4406841/Ness_Blue_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/ness-digital-engineering-acquires-intricity—a-new-york-based-company-specializing-in-data-strategy-governance-modernization-and-monetization-302139799.html
Artificial Intelligence
Körber Pharma and Siemens Take the Lead in ABI Research’s MES Software for Pharmaceutical, Biotechnology, and Cell & Gene Manufacturing Competitive Ranking
LONDON, May 8, 2024 /PRNewswire/ — The new Competitive Assessment by global technology intelligence firm ABI Research provides an in-depth and unbiased examination of the solutions offered by 13 manufacturing execution system (MES) software suppliers targeting pharmaceutical, biotech, and cell & gene manufacturing. The companies evaluated and ranked are:
Market Leaders: Körber Pharma, Siemens, Apprentice, Rockwell Automation, and TulipMainstream: Dassault Systèmes, GE Digital, Honeywell, Emerson, MPDV, MasterControl, ParsecFollowers: Sepasoft
“Overall, the MES software market for pharmaceutical, biotechnology, and cell & gene manufacturing is highly competitive, and the top innovators offer very comparable solutions. Technology vendors are aggressively developing new functionality, and competitors must closely watch and identify areas where they can match or leapfrog software capabilities,” explains James Prestwood, Industrial & Manufacturing Industry Analyst at ABI Research.
A total of ten overarching criteria were chosen for the purposes of this analysis and segmented across innovation and implementation clusters. These include how comprehensive the solution is and what innovative functionality it offers, data visibility, accessibility, and security within the platform, the user experience, and the capacity of worker augmentation, the MES’s contribution to manufacturers digital thread capabilities, and the alignment of the MES software with the pharmaceutical, biotechnology, and cell & gene manufacturing markets. In addition, the report evaluates MES vendor’s ability to deliver rapid time to value, their experience in delivering the software to manufacturers, the extensiveness of the vendor’s partnership base, the support for SME manufacturers, and the comprehensiveness of the software’s pricing options.
Körber Pharma and Siemens came out on top in the competitor ranking, with both firms scoring well across all criteria. Apprentice ranked as the top innovator in the assessment, offering a wide range of strong functionality designed specifically for life sciences manufacturing, an excellent cloud-native design, and comprehensive low/no-code capabilities. Dassault Systèmes scored particularly well in the implementation criteria, ranking second, with its center-of-excellence deployment model allowing manufacturers to quickly and consistently deploy and scale DELMIA Apriso.
“Pharmaceutical, biotech, and cell & gene manufacturing have been slow to embrace digital transformation but are now catching up. The industry’s strict regulations mean new solutions must be proven, and a premium should be placed on extensive deployment experiences when choosing solutions and technology partners,” Prestwood concludes.
These findings are from ABI Research’s MES Software for Pharmaceutical, Biotech, and Cell & Gene Therapy Manufacturing Competitive Ranking report. This report is part of the company’s Industrial and Manufacturing Markets research service, which includes research, data, and ABI Insights. Based on extensive primary interviews, Competitive Ranking reports offer comprehensive analysis of implementation and innovation strategies to offer unparalleled insight into a company’s performance and standing compared to its competitors.
About ABI Research
ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.
ABI Research是一家全球性的技术情报公司，拥有得天独厚的优势，充当终端市场公司和技术解决方案提供商之间的桥梁，通过提供独家研究和专业性指导，推动成功的技术实施和提供经证明可吸引和留住客户的战略，无缝连接这两大主体。
For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.
Contact Info:
GlobalDeborah Petrara Tel: +1.516.624.2558 [email protected]
Logo – https://mma.prnewswire.com/media/2309035/4693374/ABI_Research_2024.jpg
View original content:https://www.prnewswire.co.uk/news-releases/korber-pharma-and-siemens-take-the-lead-in-abi-researchs-mes-software-for-pharmaceutical-biotechnology-and-cell–gene-manufacturing-competitive-ranking-302139303.html
-
Artificial Intelligence5 days agoCleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention
-
Uncategorized6 days agoImproving the Developer Journey in Crafting Artificial Intelligence Applications
-
Uncategorized6 days ago
Unveiling the Complex Psychological Implications of Artificial Intelligence
-
Artificial Intelligence5 days ago5G Enterprise Market Projected to Reach $115.81 billion by 2030 – Exclusive Report by 360iResearch
-
Artificial Intelligence5 days agoBitrue expands Bitcoin Runes Offerings with GPTV Listing and Staking Options
-
Artificial Intelligence5 days agoInnodisk Introduces iCAP Air: Advancing Air Quality Management through Autonomous Decision-Making
-
Artificial Intelligence6 days agoVirtual Assistant Market Size to Grow USD 8613.5 Million by 2030 at a CAGR of 22.3% | Valuates Reports
-
Artificial Intelligence5 days agoAppian Named a Leader in the 2024 Gartner® Magic Quadrant™ for Process Mining Platforms Report
